期刊文献+

^(99m)Tc-HL91显像监测荷瘤鼠高压氧后乏氧状况

Study of ^(99m)Tc-HL91 imaging to monitor hypoxiain mice tumor after hyperbaric of oxygen
下载PDF
导出
摘要 目的99mTc-HL91乏氧显像评价肿瘤高压氧后的乏氧状况。方法20只荷H22肝癌KM小鼠随机分为4组,每组5只;(1)对照组,只进行99mTc-HL91乏氧显像;(2)15 min组,出高压氧舱后15 min行99mTc-HL91乏氧显像;(3)30 min组,出高压氧舱后30 min行99mTc-HL91乏氧显像;(4)60 min组,出高压氧舱后60 min行99mTc-HL91乏氧显像。在平面图像上,通过核医学感兴趣区(regionfinteresting,ROI)技术,计算肿瘤与对侧相应部位放射性比值(T/NT),图像采集结束后立即处死小鼠,完整剥离肿瘤,称重并计算放射性计数,计算肿瘤微分摄取率(DUR)。结果15 min组、30 min组DUR及T/NT与对照组比较,差异有统计学意义(P<0.05),60 min组与对照组比较,差异无统计学意义(P>0.05)。结论99mTc-HL91显像是一种有价值的评价肿瘤高压氧后乏氧状况的方法。 Objective To evaluate whether ^99mTc-HL91 hypoxia imagining could monitor the status of tumor hypoxia after hyperbaric oxygen. Methods Twenty bearing 1-122 tumor KM mice were randomly divided into 4 groups, 5 mice/group: The control group: only to carry on ^99mTc-HL91 hypoxia imaging. The 15 minute group, to carry on ^99mTc- HL91 hypoxia imaging at 15 minute after hyperbaric oxygen. The 30 minute group, to perform ^99mTc-HL91 hypoxia imaging at 30 minute after hyperbaric oxygen. The 60 minute group, to perform ^99mTc-HL91 hypoxia imaging at 60 minute after hyperbaric oxygen. ROI were drawn around tumor and contralateral muscles in planar images to calculate the T/NT, then the tumor was excised, weighted and the radioactivity was measured. Differential uptake ratio(DUR) was computed to quantitate the tracer uptake. Results Compared with the control group, the tumor DUR and T/NT of 15 minute group and 30 minute group were significantly different ( P 〈 0.05), 60 minute group suggested no significant difference( P 〉 0. 05). Conclusion The ^99mTc-HLgl hypexia imaging might be valuable in evaluating the status of tumor hypoxia after hyperbaric oxygen.
出处 《河北医药》 CAS 2008年第8期1103-1105,共3页 Hebei Medical Journal
关键词 ^99MTC-HL91 乏氧显像 高压氧 肿瘤 ^99mTc-HLgl hypoxia imaging hyperbaric oxygen tumor
  • 相关文献

参考文献6

  • 1王兰雪,卢付河,张小敏.氧在肿瘤放射治疗中的作用[J].河北医药,1997,19(3):177-177. 被引量:1
  • 2Kinoshita Y, Kohshi K, Kunugita N, et al. Preservation of tumor oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging. Br J Cancer, 2000,82 : 88-92.
  • 3Paliament MB, Chapman JD, Urtasun RC, et al. Non-invasive assessment of human tumor hypoxia with 123I-iodoazomycinarabinoside:preliminary report of a clinical study. Br J Cancer, 1992,65:90-95.
  • 4Nunn A, Linder K, Strauss HW, et al. Nitroimidazoles and imaging hypoxia. Eur J Nucl Med, 1995,22 : 265-280.
  • 5Chapman JD, Engelhardt EL, Stobbe CC, et al. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Ncol, 1998, 46: 229-237.
  • 6周厚清,邢成,李伯南.肿瘤放射增敏剂及增敏机制研究进展[J].国外医学(肿瘤学分册),2001,28(6):432-435. 被引量:18

二级参考文献17

  • 1Huilgol NG , Chatterjee N , Mehta AR. An overview of initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancer[J ]. Int J Radiat Oncol Biol Phys, 1996,34(5): 1121-1124.
  • 2Sharma VM , Wilson WR. Radiosensitization of advanced squamous cell carcinoma of the head and neck with cisplatin during concomitant radiation therapy [J]. Eur Arch Otorhinolaryngol, 1999,256 (9):462-465.
  • 3Pradier O , Rave Frank M , Schmidberger H, et al. Effects of paclitaxel in combination with radiation on human head and neck cancer cells( ZMK-1 ), cervical squamous cell carcinoma cells(CaSki) and breastadenocarcinoma cells(mcf-7) [J]. Int J Cancef, 1999,125(1):20-27.
  • 4Zaugg K , Rocha S , Resch H , et al. Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412[J]. Cancer Res,2001,61(2):732-738.
  • 5Creane M , Seymour CB , Colucci S, et al. Radiobiological effects of docetaxel: a potential radiation sensitizer[J]. Iht J Radiat Biol,1999,75 (6): 731-737.
  • 6ChenM , Hough AM , Lawrence TS. The roleof p53 ingemcitabine-mediated cytotoxicity and radiosensitization[J]. Cancer Chemother Pharmacol, 2000,45 (5): 369-374.
  • 7Inomata T , Ogawa Y , Itoh S , et al. Lung metastasis suppression of the bifunctional new radiosensitizer KIN-806[J]. Int J Mol Med, 1999,4(3) :257-260.
  • 8Inomata T , Oqawa Y , Nishioka A , et al. The immunopotentiation effects of the bifunctional radiosensitizer KIN-806 in comparison with its analogs KIN-804 and KIN-844[J]. Oncol Rep, 1999,6(6): 1209-1212.
  • 9Park SH , Chrng YM , Lee YS , et al. Antisense of human peroxiredoxin Ⅱ enhances radiation-induced cell death[J ]. Clin Cancer Res, 2000,6 (12): 4915-4020.
  • 10Nguyen NP , Sallah S. Combined chemotherapy and radiation in the treatment of locally advanced head and neck cancers[J]. In vivo,2000,14(1) :35-39.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部